| Genetic inactivation of dopamine D1 but not D2 receptors inhibits L-DOPA–induced dyskinesia and histone activation S Darmopil, AB Martín, IR De Diego, S Ares, R Moratalla Biological psychiatry 66 (6), 603-613, 2009 | 288 | 2009 |
| Activation of DREAM (downstream regulatory element antagonistic modulator), a calcium-binding protein, reduces L-DOPA-induced dyskinesias in mice I Ruiz-DeDiego, B Mellstrom, M Vallejo, JR Naranjo, R Moratalla Biological Psychiatry 77 (2), 95-105, 2015 | 58 | 2015 |
| Striatal activation by optogenetics induces dyskinesias in the 6‐hydroxydopamine rat model of Parkinson disease L F. Hernández, I Castela, I Ruiz‐DeDiego, JA Obeso, R Moratalla Movement Disorders 32 (4), 530-537, 2017 | 56 | 2017 |
| Optostimulation of striatonigral terminals in substantia nigra induces dyskinesia that increases after L‐DOPA in a mouse model of Parkinson's disease E Keifman, I Ruiz‐DeDiego, DE Pafundo, RM Paz, O Solís, MG Murer, ... British Journal of Pharmacology 176 (13), 2146-2161, 2019 | 40 | 2019 |
| Dopaminergic regulation of olfactory type G‐protein α subunit expression in the striatum I Ruiz‐DeDiego, JR Naranjo, D Hervé, R Moratalla Movement Disorders 30 (8), 1039-1049, 2015 | 32 | 2015 |
| Genetic Knockdown of mGluR5 in Striatal D1R-Containing Neurons Attenuates l-DOPA-Induced Dyskinesia in Aphakia Mice JR García-Montes, O Solís, J Enríquez-Traba, I Ruiz-DeDiego, ... Molecular Neurobiology 56, 4037-4050, 2019 | 15 | 2019 |
| Genetic enhancement of Ras-ERK pathway does not aggravate L-DOPA-induced dyskinesia in mice but prevents the decrease induced by lovastatin I Ruiz-DeDiego, S Fasano, O Solís, JR Garcia-Montes, J Brea, MI Loza, ... Scientific Reports 8 (1), 15381, 2018 | 13 | 2018 |
| Intracellular signaling pathways involved in L-DOPA-induced dyskinesias I Ruiz de Diego Universidad Complutense de Madrid, 2015 | | 2015 |
| Priority Communication I Ruiz-DeDiego, B Mellstrom, M Vallejo, JR Naranjo, R Moratalla | | |
